Home

Dr. Larry Lutwick has been confirmed to have a license in New York

Beyond Anthrax: The Weaponization of Infectious Diseases

Too low to display


View Larry Lutwick’s professional profile on LinkedIn

Larry I. Lutwick, MD practices Infectious Disease in Kalamazoo, MI. Dr. Lutwick graduated from University of Washington School of Medicine in 1972 and has been in practice for 41 years. He completed a residency at Barnes Jewish Hospital. Dr. Lutwick also specializes in Internal Medicine. Dr. Lutwick accepts multiple insurance plans including Aetna, Blue Cross Blue Shield of Michigan and Medicare. Dr. Lutwick is board certified in Internal Medicine. Dr. Lutwick also practices at Larry I Lutwick MD in Brooklyn, NY. In addition to English, Dr. Lutwick's practice supports these languages: Korean and Spanish.

To send an email to Larry Lutwick please complete the short form below. Please note that all enquiries should relate specifically to IDCases. All the fields are required so please make sure you complete them all otherwise we won't be able to send your message.

Join Facebook to connect with Larry Lutwick and others you may know

  • Dr. Larry Lutwick MD
  • Larry Lutwick - Editor-in-Chief - IDCases - Elsevier

    Last month a valuable new 17-chapter book on biodefense issues was published titled Beyond Anthrax: The Weaponization of Infectious Diseases. The editors are Dr. Larry Lutwick and Suzanne Lutwick and the publisher is Springer/Humana Press. Updated chapters devoted to many of the CDC Category A and B threat agents are followed by excellent chapters on media, legal, psychosocial, and public health infrastructure perspectives.

    Last month a valuable new 17-chapter book on biodefense issues was published titled Beyond Anthrax: The Weaponization of Infectious Diseases. The editors are Dr. Larry Lutwick and Suzanne Lutwick and the publisher is Springer/Humana Press. Updated chapters devoted to many of the CDC Category A and B threat agents are followed by excellent chapters on media, legal, psychosocial, and public health infrastructure perspectives.